申请人:Eli Lilly Industries Limited
公开号:US04230716A1
公开(公告)日:1980-10-28
Hydantoin compounds are described of the formula (I) : ##STR1## wherein R.sup.1 is phenyl, C.sub.1-4 hydroxyalkyl or carboxy C.sub.1-4 alkyl and wherein R.sub.2 is C.sub.1-6 alkyl. The compounds are useful in the prophylactic treatment of immediate hypersensitivity diseases including asthma.
Hydantoin化合物的结构式为(I):##STR1##其中R.sup.1是苯基、C.sub.1-4羟基烷基或羧基C.sub.1-4烷基,R.sub.2是C.sub.1-6烷基。这些化合物在预防治疗包括哮喘在内的即时超敏反应性疾病中有用。